Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination

Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination

BACKGROUND:. The U.S. Food and Drug Administration has to date granted approval or emergency use authorization to three vaccines against severe acute respiratory syndrome coronavirus 2 and coronavirus disease 2019. In clinical trials and real-use observational studies, the Pfizer-BioNTech BNT162b2 m...

Full description

Saved in:
Bibliographic Details
Main Authors: Benjamin Kahn, BA, Sokratis A. Apostolidis, MD, Vatsal Bhatt, MD, Allison R. Greenplate, PhD, Staci Kallish, DO, Anthony LaCava, MD, Alfredo Lucas, BA, Nuala J. Meyer, MD, MS, Dan Negoianu, MD, Alexis R. Ogdie, MD, MSCE, Michael G. S. Shashaty, MD, MSCE, Patricia A. Takach, MD, Leah Zuroff, MD, MS, E. John Wherry, PhD, George L. Anesi, MD, MSCE, MBE
Format: article
Language:EN
Published: Wolters Kluwer 2021
Subjects:
Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Online Access:https://doaj.org/article/2bf181e5ca184060a76eb3a8b345f61c
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items